NCT06079034

Brief Summary

There has been increasing use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. This study seeks to leverage the increased use of VA ECMO in this cohort to enrich an evaluation of the differences in rate of intracranial hemorrhage and ischemic stroke between venovenous (VV) and VA ECMO among infants with respiratory failure where clinicians may choose either strategy. This project is a retrospective review of data in the ELSO registry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,058

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

October 18, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2023

Completed
Last Updated

April 4, 2024

Status Verified

April 1, 2024

Enrollment Period

2 months

First QC Date

September 22, 2023

Last Update Submit

April 3, 2024

Conditions

Keywords

ECMO

Outcome Measures

Primary Outcomes (1)

  • Neurologic Injury

    The outcome will be the composite occurrence of neurologic injury (ischemic stroke, intracranial hemorrhage, and brain death) that arises during critical illness supported by extracorporeal life support (ECLS) as reported to the Extracorporeal Life Support Organization (ELSO) registry, coded as a 0/1 variable (0 = no occurrence was reported during or after ECMO; 1 = one or more occurrence was reported).

    during critical illness supported by ECLS up to 14 days after ECLS stop time

Secondary Outcomes (4)

  • Mortality

    through study completion (ECLS hospital discharge), an average of 2 months

  • Duration of ECMO support

    during the procedure (ECLS support)

  • Discharge Disposition

    through study completion (ECLS hospital discharge), an average of 2 months

  • Individual neurologic injury

    during the procedure (ECLS support), and up to 14 days days after ECLS stop time

Study Arms (2)

Venovenous ECMO

Procedure: Venovenous ECMO

Venoarterial ECMO

Procedure: Venoarterial ECMO

Interventions

Initial support type of venovenous ECMO via a dual-lumen on two-site VV ECMO cannulation strategy

Venovenous ECMO

Initial support type of venoarterial ECMO

Venoarterial ECMO

Eligibility Criteria

Age0 Days+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients reported to the ELSO registry weighing less than or equal to 10 kilograms at the start of ECMO receiving ECMO for pulmonary support

You may qualify if:

  • Patient weighed less than or equal to 10kg at start of ECMO
  • Pulmonary support was the indication for ECLS
  • Initial cannulation strategy was VV or VA
  • The run occurred during the period 2013-2023

You may not qualify if:

  • Patient had CDH
  • Patient was post-cardiotomy
  • Non-conventional initial cannulation strategies were employed, such as
  • Central Cannulation (surrogate for inability to achieve peripheral cannulation)
  • Veno-veno-arterial ECMO
  • Initial cannulation approach reported as "other"
  • Patient was transported into or out of ELSO center on ECMO support
  • Patient had pre-ECLS Cardiac Arrest
  • Patient did not have subsequent ECMO runs in the ELSO registry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Interventions

Extracorporeal Membrane Oxygenation

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Respiratory TherapyTherapeuticsExtracorporeal CirculationSurgical Procedures, Operative

Study Officials

  • Joseph G Kohne

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

September 22, 2023

First Posted

October 12, 2023

Study Start

October 18, 2023

Primary Completion

December 12, 2023

Study Completion

December 12, 2023

Last Updated

April 4, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Data received from the ELSO Registry is available to qualified researchers through an ELSO data request

Locations